Combination antiretroviral therapy and improvements in mental health: Results from a nationally representative sample of persons undergoing care for HIV in the United States

Kitty S. Chan, Maria Orlando, Geoffrey Joyce, Allen L. Gifford, M. Audrey Burnam, Joan S. Tucker, Cathy D. Sherbourne

Research output: Contribution to journalArticle

Abstract

Objective: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. Analysis: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. Results: The reduction in psychiatric symptoms was comparable across all treatment groups (p > .05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. Conclusion: ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.

Original languageEnglish (US)
Pages (from-to)104-111
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume33
Issue number1
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Mental Health
HIV
Therapeutics
Psychiatry
Opportunistic Infections
Linear Models
CD4 Lymphocyte Count
Quality of Life
Interviews
Survival

Keywords

  • AIDS
  • Antiretroviral therapy
  • HIV
  • Mental health
  • Protease inhibitors

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Combination antiretroviral therapy and improvements in mental health : Results from a nationally representative sample of persons undergoing care for HIV in the United States. / Chan, Kitty S.; Orlando, Maria; Joyce, Geoffrey; Gifford, Allen L.; Burnam, M. Audrey; Tucker, Joan S.; Sherbourne, Cathy D.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 33, No. 1, 01.05.2003, p. 104-111.

Research output: Contribution to journalArticle

Chan, Kitty S. ; Orlando, Maria ; Joyce, Geoffrey ; Gifford, Allen L. ; Burnam, M. Audrey ; Tucker, Joan S. ; Sherbourne, Cathy D. / Combination antiretroviral therapy and improvements in mental health : Results from a nationally representative sample of persons undergoing care for HIV in the United States. In: Journal of Acquired Immune Deficiency Syndromes. 2003 ; Vol. 33, No. 1. pp. 104-111.
@article{9fddef1ee4c94d03ab210b5050a14511,
title = "Combination antiretroviral therapy and improvements in mental health: Results from a nationally representative sample of persons undergoing care for HIV in the United States",
abstract = "Objective: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. Analysis: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. Results: The reduction in psychiatric symptoms was comparable across all treatment groups (p > .05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. Conclusion: ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.",
keywords = "AIDS, Antiretroviral therapy, HIV, Mental health, Protease inhibitors",
author = "Chan, {Kitty S.} and Maria Orlando and Geoffrey Joyce and Gifford, {Allen L.} and Burnam, {M. Audrey} and Tucker, {Joan S.} and Sherbourne, {Cathy D.}",
year = "2003",
month = "5",
day = "1",
language = "English (US)",
volume = "33",
pages = "104--111",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Combination antiretroviral therapy and improvements in mental health

T2 - Results from a nationally representative sample of persons undergoing care for HIV in the United States

AU - Chan, Kitty S.

AU - Orlando, Maria

AU - Joyce, Geoffrey

AU - Gifford, Allen L.

AU - Burnam, M. Audrey

AU - Tucker, Joan S.

AU - Sherbourne, Cathy D.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Objective: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. Analysis: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. Results: The reduction in psychiatric symptoms was comparable across all treatment groups (p > .05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. Conclusion: ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.

AB - Objective: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. Analysis: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. Results: The reduction in psychiatric symptoms was comparable across all treatment groups (p > .05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. Conclusion: ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.

KW - AIDS

KW - Antiretroviral therapy

KW - HIV

KW - Mental health

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0037696566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037696566&partnerID=8YFLogxK

M3 - Article

C2 - 12792362

AN - SCOPUS:0037696566

VL - 33

SP - 104

EP - 111

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -